Parenti, Ilaria https://orcid.org/0000-0002-1825-6237
Hesters, Alina https://orcid.org/0009-0000-8039-3040
Gil-Salvador, Marta https://orcid.org/0000-0001-6858-1575
Duffy, Laura https://orcid.org/0009-0007-3297-7747
Kanber, Deniz
Beygo, Jasmin
Kerkhof, Jennifer https://orcid.org/0000-0003-1245-6606
Steenpaß, Laura
Leitão, Elsa https://orcid.org/0000-0001-5051-9714
Woestefeld, Julia https://orcid.org/0000-0002-9796-2323
Boone, Philip M.
Kao, Emeline M.
Alabdi, Lama
Aldhalaan, Hesham M.
Alkuraya, Fowzan S.
Alshammari, Muneera J.
Antonarakis, Stylianos E. https://orcid.org/0000-0001-8907-5823
Basel, Donald
Cassinari, Kevin
de Polli Cellin, Laurana
Clause, Amanda R. https://orcid.org/0000-0002-2078-7280
de Lima Jorge, Alexander Augusto https://orcid.org/0000-0003-2567-7360
de Castro Leal, Andréa https://orcid.org/0000-0003-1284-8618
Collins, Stephan C. https://orcid.org/0000-0002-1533-3380
Durand, Benjamin https://orcid.org/0000-0003-3434-1172
Eckhold, Juliane
Hashem, Mais O.
Jayakar, Parul
Khan, Arif O.
Kato, Kohji
Kubica, Regina
Lyon, Gholson J. https://orcid.org/0000-0002-5869-0716
Marchi, Elaine
McCarrier, Julie
Kimmig, Lara K.
Mizuno, Seiji
Nicolas, Gael https://orcid.org/0000-0001-9391-7800
Nishio, Yosuke https://orcid.org/0000-0003-3543-7491
Ogi, Tomoo https://orcid.org/0000-0002-5492-9072
Pié, Juan
Prell, Jordyn
Puisac, Beatriz https://orcid.org/0000-0003-0170-7326
Ramos, Feliciano J. https://orcid.org/0000-0002-5732-2209
Ranza, Emmanuelle
Redin, Claire
Rush, Eric
Saitoh, Shinji https://orcid.org/0000-0001-6911-3351
Shamseldin, Hanan E.
Starling, Susan
Astiazaran-Symonds, Esteban
Eltahir, Sara H.
Kuechler, Alma
Sadikovic, Bekim https://orcid.org/0000-0001-6363-0016
Yalcin, Binnaz https://orcid.org/0000-0002-1924-6807
Wendt, Kerstin S. https://orcid.org/0000-0003-0235-1237
Kaiser, Frank J.
Article History
Received: 17 October 2025
Accepted: 16 March 2026
First Online: 30 March 2026
Competing interests
: A.A.L.J. reported receiving consulting fees and grants from BioMarin, Novo Nordisk and BridgeBio. S.E.A. is a co-founder and CEO of Medigenome, Swiss Institute of Genomic Medicine. F.S.A is a paid employee of Lifera Omics. A.R.C is a former employee and current shareholder of Illumina. All other authors declare no conflict of interest.